XML 86 R60.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
Oct. 30, 2013
shares
Dec. 31, 2021
USD ($)
plan
$ / shares
shares
Sep. 30, 2019
shares
Dec. 31, 2021
USD ($)
plan
$ / shares
shares
Dec. 31, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
Dec. 31, 2017
shares
Dec. 05, 2019
shares
Dec. 31, 2018
shares
Dec. 31, 2016
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Unrecognized compensation expense | $   $ 22,400   $ 22,400            
Number of equity compensation plans | plan   3   3            
Granted (in shares)       1,614,997            
Weighted average grant date fair value (in dollars per share) | $ / shares       $ 8.57 $ 10.82 $ 20.70        
Aggregate intrinsic value of options exercised | $       $ 7,500 $ 600 $ 4,200        
Estimated fair value of common stock (in dollars per share) | $ / shares   $ 7.02   $ 7.02            
Outstanding stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Compensation cost, weighted average recognition period       2 years 2 months 1 day            
Restricted stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Compensation cost, weighted average recognition period       2 years 7 months 17 days            
Unrecognized compensation expense | $   $ 12,600   $ 12,600            
Shares issued (in shares)       660,926            
Fair value of restricted stock vested | $       $ 9,200 $ 11,500 $ 9,800        
Vested (in shares)       274,488            
Non-vested shares cancelled and replaced (in shares)     43,071 218,721            
Stock-based compensation, non vesting (in shares)   977,244   977,244 809,527          
Restricted stock | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based awards, vesting period       1 year            
Restricted stock | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock-based awards, vesting period       4 years            
Restricted Stock with Non-Market Performance Conditions                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares issued (in shares)             98,817      
RSUs                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Compensation cost, weighted average recognition period       3 years            
Unrecognized compensation expense | $   $ 3,000   $ 3,000            
Shares issued (in shares)       100,322            
Vested (in shares)       30,958            
Non-vested shares cancelled and replaced (in shares)       19,673            
Stock-based compensation, non vesting (in shares)   156,873 43,071 156,873 107,182          
Employee stock purchase plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Shares issued (in shares)       645,814            
Lump sum percentage (equal to)       85.00%            
Fair value equivalent of common stock | $       $ 25            
Amended And Restated Omnibus Incentive Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equity awards (in shares)   10,229,068   10,229,068         4,500,000  
Inducement Award Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equity awards (in shares)             874,500 100,000   418,000
Shares issued (in shares)   602,952                
Two Thousand and Five Aerie Pharmaceutical Stock Plan                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Granted (in shares) 0